The Global HIV Vaccine Enterprise is an alliance of independent organizations around the world dedicated to accelerating the development of a preventive HIV vaccine by:

• Shared scientific plan: Implementing a strategic plan for HIV vaccine research that spans vaccine discovery, product development and manufacturing, and clinical trials
• Increased resources: Mobilizing significant new funding to achieve the scientific plan
• Greater collaboration: Promoting more efficient, faster ways for researchers to share successes and failures and avoid duplication of efforts